B. Watkins

发表

Efficacy of Superoxide Dismutase Mimetic M40403 in Attenuating Radiation-Induced Oral Mucositis in Hamsters

S. Sonis, E. Fey, C. Murphy, 2008, Clinical Cancer Research.

Serum amyloid P ameliorates radiation-induced oral mucositis and fibrosis

Michael S. Kramer, D. Knight, L. Murray, 2010, Fibrogenesis & tissue repair.

Bony changes in the jaws of rats treated with zoledronic acid and dexamethasone before dental extractions mimic bisphosphonate-related osteonecrosis in cancer patients.

S. Sonis, M. Lerman, B. Watkins, 2009, Oral oncology.

Perturbations in factors that modulate osteoblast functions in vitamin B6 deficiency.

D. Howell, P. Hauschka, M. Grynpas, 2000, Canadian journal of physiology and pharmacology.

Attenuation of radiation- and chemoradiation-induced mucositis using gamma-D-glutamyl-L-tryptophan (SCV-07).

S. Sonis, E. Fey, B. Watkins, 2010, Oral diseases.

Gene expression changes in peripheral blood cells provide insight into the biological mechanisms associated with regimen-related toxicities in patients being treated for head and neck cancers.

M. Ramoni, S. Sonis, R. Haddad, 2007, Oral oncology.

AG013, a mouth rinse formulation of Lactococcus lactis secreting human Trefoil Factor 1, provides a safe and efficacious therapeutic tool for treating oral mucositis.

Bernard Coulie, S. Sonis, B. Coulie, 2010, Oral oncology.

Velafermin (rhFGF-20) reduces the severity and duration of hamster cheek pouch mucositis induced by fractionated radiation

S. Sonis, B. Watkins, G. Ara, 2008, International journal of radiation biology.

The effect of the immunomodulatory peptide gamma-D-glutamyl-L-tryptophan in leukemia, lymphoma, and head and neck cancer xenograft models.

S. Sonis, J. Papkoff, B. Watkins, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Human fibroblast growth factor 20 (FGF-20; CG53135-05): A novel cytoprotectant with radioprotective potential

O. Folkerts, T. MacLachlan, E. Fey, 2005, International journal of radiation biology.

Effect of a mouth rinse formulation with human trefoil factor 1-secreting Lactococcus lactis in experimental oral mucositis in hamsters.

S. Sonis, B. Coulie, B. Watkins, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

AG013, a mouth rinse formulation of Lactococcus lactis secreting human Trefoil Factor 1, provides a safe and efficacious therapeutic tool for treating oral mucositis.

S. Sonis, B. Coulie, S. Neirynck, 2010, Oral Oncology.

Single-Dose Prevention or Short-Term Treatment with Fibroblast Growth Factor-20 (CG53135-05)Reduces the Severity and Duration of Oral Mucositis.

S. Sonis, E. Fey, B. Watkins, 2005, Supportive cancer therapy.

Efficacy of Superoxide Dismutase Mimetic M40403 in Attenuating Radiation-Induced Oral Mucositis in Hamsters

S. Sonis, E. Fey, C. Murphy, 2008, Clinical Cancer Research.

Resistance of human immunodeficiency virus type 1 to neutralization by natural antisera occurs through single amino acid substitutions that cause changes in antibody binding at multiple sites

J. Robinson, M. Reitz, M. Robert-Guroff, 1996, Journal of virology.